neuroscience

Why do some people prefer stable, predictable lives while others prefer frequent changes? Findings of a study may hold answers to this question.

Hospital emergency rooms treat more than 170,000 children each year for sports-related traumatic brain injuries. What do parents and coaches need to know to protect their kids and players?

The Semel Institute for Neuroscience and Human Behavior is one of a handful of hospitals and clinics nationwide that offer a treatment that works in a fundamentally different way than drugs.

Researchers at UCLA have developed a molecular compound that improves balance and coordination in mice with the early stage of the disorder.

Deletions or duplications of DNA along 22nd chromosome hint at biological underpinnings of these neuropsychiatric disorders.

UCLA researchers found that women and men exhibit different changes in their brain’s reward centers, which suggests different reasons for overeating.

The findings by UCLA researchers could help scientists replicate or control the way axons grow, which could be applicable for diseases that affect the nervous system.

Paradoxically, the strong relationship between stress level and the tendency to forget course material was most prevalent among students who are most confident in their own mathematical abilities.

A UCLA study has traced the phenomenon to the same neurons that go awry during Huntington’s disease, Parkinson’s disease and Tourette’s syndrome.

Justin Cho was experiencing a rare form of epileptic seizures caused by a lesion in his brain; UCLA Mattel Children’s Hospital used a new minimally invasive approach to stop them.

The team discovers a biological marker that may help to identify youths at risk of poor outcomes and prevent cognitive decline.

The study could pave the way for understanding and treating neurological disorders, and for developing computers that “think” more like humans.

The researchers identified genes that they believe control hundreds of other genes linked to Alzheimer’s disease, Parkinson’s disease, depression and several other disorders.

UCLA School of Nursing researchers found that people with a certain genetic variation who took donepezil for the condition had a faster cognitive decline than those who took a placebo.

The researchers will identify biomarkers associated with the development of epilepsy and develop therapies designed to prevent or modify the condition.

After 10 weeks, children who had received a UCLA-developed intervention for autism were spending more time interacting with others rather than playing independently.

The discovery could have important implications for treating white matter strokes, a major cause of dementia that also accelerate Alzheimer’s disease.

The findings could help improve upon standard behavioral therapy, in which people are exposed to the objects they’re afraid of — which can be frightening enough that some cannot complete treatment.

The approach being tested at UCLA is designed to boost patients’ abilities to move their own hands; it’s unique because the device is implanted in the spine instead of the brain.

UCLA scientists have already established national and international collaborations, begun a series of studies and implemented a program that screens and treats students for depression.

Neuroscientists at UCLA have developed a new technique for studying a particular type of cell in the brain known as an astrocyte that may play a role in diseases such as Lou Gehrig’s disease and Alzheimer's disease.

A new component of the successful Optimists brand campaign, the conversations will focus on newsworthy and culturally significant topics, including sports concussions, gratitude and mentorship.

UCLA’s Dr. Daniel Geschwind said the findings could point the way to the development of drugs that reverse the specific type of gene activity patterns in the brains of people with the disorder.

UCLA’s Bonnie Zima and colleagues found that the number of pediatric hospitalizations that included a psychiatric diagnosis rose 138 percent between 2005 and 2014.

A study by UCLA researchers found that a noninvasive method can help to determine whether an individual will enter remission after just one week of medical treatment.